Kawasaki T (1967) Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children. Arerugi 16:178–222
Kawasaki T, Kosaki F, Okawa S, Shigematsu I, Yanagawa H (1974) A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan. Pediatrics 54:271–276
Article CAS PubMed Google Scholar
Burns JC, Glodé MP (2004) Kawasaki syndrome. Lancet 364:533–544. https://doi.org/10.1016/s0140-6736(04)16814-1
Newburger JW, Takahashi M, Burns JC (2016) Kawasaki disease. J Am Coll Cardiol 67:1738–1749. https://doi.org/10.1016/j.jacc.2015.12.073
McCrindle BW, Rowley AH, Newburger JW et al (2017) Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association. Circulation 135:e927–e999. https://doi.org/10.1161/cir.0000000000000484
McCrindle BW, Rowley AH (2019) Improving coronary artery outcomes for children with Kawasaki disease. Lancet 393:1077–1078. https://doi.org/10.1016/s0140-6736(18)33133-7
Furusho K, Kamiya T, Nakano H et al (1984) High-dose intravenous gammaglobulin for Kawasaki disease. Lancet 2:1055–1058. https://doi.org/10.1016/s0140-6736(84)91504-6
Article CAS PubMed Google Scholar
Newburger JW, Takahashi M, Burns JC et al (1986) The treatment of Kawasaki syndrome with intravenous gamma globulin. N Engl J Med 315:341–347. https://doi.org/10.1056/nejm198608073150601
Article CAS PubMed Google Scholar
Travaline JM, Hamilton SM, Ringel RE, Laschinger JC, Ziskind AA (1991) Cardiac transplantation for giant coronary artery aneurysms complicating Kawasaki disease. Am J Cardiol 68:560–561. https://doi.org/10.1016/0002-9149(91)90801-q
Article CAS PubMed Google Scholar
Oates-Whitehead RM, Baumer JH, Haines L, Love S, Maconochie IK, Gupta A, Roman K, Dua JS, Flynn I (2003) Intravenous immunoglobulin for the treatment of Kawasaki disease in children. Cochrane Database Syst Rev 2003:CD004000. https://doi.org/10.1002/14651858.CD004000
Article PubMed PubMed Central Google Scholar
Ae R, Makino N, Kosami K, Kuwabara M, Matsubara Y, Nakamura Y (2020) Epidemiology, treatments, and cardiac complications in patients with Kawasaki disease: the nationwide survey in Japan, 2017–2018. J Pediatr 225:23-29.e22. https://doi.org/10.1016/j.jpeds.2020.05.034
Makino N, Nakamura Y, Yashiro M et al (2015) Descriptive epidemiology of Kawasaki disease in Japan, 2011–2012: from the results of the 22nd nationwide survey. J Epidemiol 25:239–245. https://doi.org/10.2188/jea.JE20140089
Makino N, Nakamura Y, Yashiro M et al (2018) Epidemiological observations of Kawasaki disease in Japan, 2013–2014. Pediatr Int 60:581–587. https://doi.org/10.1111/ped.13544
Makino N, Nakamura Y, Yashiro M, Kosami K, Matsubara Y, Ae R, Aoyama Y, Yanagawa H (2019) Nationwide epidemiologic survey of Kawasaki disease in Japan, 2015–2016. Pediatr Int 61:397–403. https://doi.org/10.1111/ped.13809
Wallace CA, French JW, Kahn SJ, Sherry DD (2000) Initial intravenous gammaglobulin treatment failure in Kawasaki disease. Pediatrics 105:E78. https://doi.org/10.1542/peds.105.6.e78
Article CAS PubMed Google Scholar
Nakamura Y, Yashiro M, Uehara R, Sadakane A, Tsuboi S, Aoyama Y, Kotani K, Tsogzolbaatar EO, Yanagawa H (2012) Epidemiologic features of Kawasaki disease in Japan: results of the 2009–2010 nationwide survey. J Epidemiol 22:216–221. https://doi.org/10.2188/jea.je20110126
Article PubMed PubMed Central Google Scholar
Kuo HC, Liang CD, Wang CL, Yu HR, Hwang KP, Yang KD (2010) Serum albumin level predicts initial intravenous immunoglobulin treatment failure in Kawasaki disease. Acta Paediatr 99:1578–1583. https://doi.org/10.1111/j.1651-2227.2010.01875.x
Durongpisitkul K, Soongswang J, Laohaprasitiporn D, Nana A, Prachuabmoh C, Kangkagate C (2003) Immunoglobulin failure and retreatment in Kawasaki disease. Pediatr Cardiol 24:145–148. https://doi.org/10.1007/s00246-002-0216-2
Article CAS PubMed Google Scholar
Kuo HC, Yang KD, Liang CD, Bong CN, Yu HR, Wang L, Wang CL (2007) The relationship of eosinophilia to intravenous immunoglobulin treatment failure in Kawasaki disease. Pediatr Allergy Immunol 18:354–359. https://doi.org/10.1111/j.1399-3038.2007.00516.x
Lin MT, Chang CH, Sun LC et al (2016) Risk factors and derived formosa score for intravenous immunoglobulin unresponsiveness in Taiwanese children with Kawasaki disease. J Formos Med Assoc 115:350–355. https://doi.org/10.1016/j.jfma.2015.03.012
Article CAS PubMed Google Scholar
Xie T, Wang Y, Fu S, Wang W, Xie C, Zhang Y, Gong F (2017) Predictors for intravenous immunoglobulin resistance and coronary artery lesions in Kawasaki disease. Pediatr Rheumatol Online J 15:17. https://doi.org/10.1186/s12969-017-0149-1
Article PubMed PubMed Central Google Scholar
Jarutach J, Roymanee S, Wongwaitaweewong K (2021) Verification of Japanese scoring systems to predict IVIG resistance and identification of predictors for IVIG resistance in Thai children with Kawasaki disease. Pediatr Cardiol 42:1799–1804. https://doi.org/10.1007/s00246-021-02668-0
Honkanen VE, McCrindle BW, Laxer RM, Feldman BM, Schneider R, Silverman ED (2003) Clinical relevance of the risk factors for coronary artery inflammation in Kawasaki disease. Pediatr Cardiol 24:122–126. https://doi.org/10.1007/s00246-002-0063-1
Article CAS PubMed Google Scholar
McCrindle BW, Li JS, Minich LL et al (2007) Coronary artery involvement in children with Kawasaki disease: risk factors from analysis of serial normalized measurements. Circulation 116:174–179. https://doi.org/10.1161/circulationaha.107.690875
Xuan W, Yao Y, Wang Y, Chen X, Yao H (2024) A nomogram for predicting coronary artery lesions in patients with Kawasaki disease. Medicine Baltimore 103:e40428. https://doi.org/10.1097/md.0000000000040428
Article CAS PubMed PubMed Central Google Scholar
Shao S, Luo C, Zhou K, Hua Y, Wu M, Liu L, Liu X, Wang C (2019) The role of age-specific N-terminal pro-brain natriuretic peptide cutoff values in predicting intravenous immunoglobulin resistance in Kawasaki disease: a prospective cohort study. Pediatr Rheumatol Online J 17:65. https://doi.org/10.1186/s12969-019-0368-8
Article PubMed PubMed Central Google Scholar
Masuda H, Ae R, Koshimizu TA et al (2022) Serum sodium level associated with coronary artery lesions in patients with Kawasaki disease. Clin Rheumatol 41:137–145. https://doi.org/10.1007/s10067-021-05881-7
Kim TH, Son Y, Lee H et al (2025) Biomarkers and related factors for the diagnosis, risk of coronary artery lesions, and resistance to intravenous immunoglobulin in Kawasaki disease: an umbrella review of meta-analyses. Pediatr Cardiol 46:1488–1504. https://doi.org/10.1007/s00246-024-03563-0
Research Committee of the Japanese Society of Pediatric Cardiology, Cardiac Surgery Committee for Development of Guidelines for Medical Treatment of Acute Kawasaki Disease (2014) Guidelines for medical treatment of acute Kawasaki disease: report of the Research Committee of the Japanese Society of Pediatric Cardiology and Cardiac Surgery (2012 revised version). Pediatr Int 56:135–158. https://doi.org/10.1111/ped.12317
Akagi T, Rose V, Benson LN, Newman A, Freedom RM (1992) Outcome of coronary artery aneurysms after Kawasaki disease. J Pediatr 121:689–694. https://doi.org/10.1016/s0022-3476(05)81894-3
Comments (0)